Verified by DRAP 🩺 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS 🏷️ Propionic acid
👨‍⚕️ Clinically Reviewed by: PakistaniBano Medical Editorial Board (Pharm.D Panel)
📅 Reviewed: November 2026 • 🔍 Authority: DRAP / WHO ATC
📦 Formulations, Pack Sizes & Retail Prices Currency: Rs.
Dosage Form Reg. No Pack Size Trade Price (TP) Maximum Retail Price (MRP)
Susp 100 mg 004595 120 ml Rs.99.00 Rs.117.00
Susp DS 200 mg 070851 90 ml Rs.34.40 Rs.41.40
Tab 200 mg 001541 50x10 Rs.582.20 Rs.685.00
Tab 200 mg 001541 10x10 Rs.336.00 Rs.396.74
Tab 400 mg 001541 25x10 Rs.771.25 Rs.908.48
Tab 600 mg — 3x12 Rs.164.55 Rs.193.26

📋 Indications & Clinical Dosage

*Pain and inflammation in rheumatic disease and other musculoskeletal disorders, fever, Mild to moderate pain including dysmenorrhea, Postoperative analgesia, Migraine, Dental pain:* Adult: Initially 300-400 mg 3-4 times a day; increased if necessary up to 600 mg 4 times a day, dose to be increased only in severe cases; maintenance 200-400 mg 3 times a day. *Mild to moderate pain, fever, Pain and inflammation of soft-tissue injuries, Pyrexia with discomfort:* Adult & Child above 12years: Initially 300-400 mg 3-4 times a day; increased if necessary up to 600 mg 4 times a day, dose to be increased only in severe cases; maintenance 200-400 mg 3 times a day Children 3-5 months: 50 mg 3 times a day, max.30 mg/kg per day; 6-11 months: 50 mg 3-4 times a day, max.30 mg/kg per day; 1-3 years: 100 mg 3 times a day, max.30 mg/kg per day; 4-6 years: 150 mg 3 times a day, max.30 mg/kg per day; 7-9 years: 200 mg 3 times a day, max.30 mg/kg per day; max. 2.4 g per day; 10-11 years: 300 mg 3 times a day, max.30 mg/kg per day; max. 2.4 g per day. *Pain and inflammation in rheumatic disease including systemic juvenile idiopathic arthritis:* Children 3 months-17 years: 30-40 mg/kg daily in 3-4 divided doses; increase up to 60 mg/kg daily in 4-6 divided doses; max. 2.4 g per day. *Post-immunization pyrexia in infants:* Children 2-3 months: 50 mg for 1 dose, followed by 50 mg after 6 hours if required.

⛔ Contraindications

Active or recurrent GI bleeding or ulceration, cerebrovascular disease, history of GI bleeding or GI perforation related to previous NSAID therapy, history of recurrent GI haemorrhage, ischaemic heart disease, heart failure, peripheral arterial disease, moderate to severe renal impairment, aspirin/anti-inflammatory induced allergy.

⚠️ Precautions & Warnings

Renal, hepatic or cardiac impairment. GI disease, allergic disorders, avoid in acute porphyrias, coagulation defects, connective-tissue disorders, Crohns disease (may be exacerbated), elderly, oedema, risk factors for cardiovascular events, ulcerative colitis (may be exacerbated), uncontrolled hypertension

🔄 Drug Interactions

Anticoagulants, thiazide diuretics, quinolones.

⚠️ Adverse Reactions / Side Effects

Angioedema, blood disorders, bronchospasm, colitis, Crohns disease, depression, diarrhoea, dizziness, drowsiness, fluid retention, GI bleeding and ulceration, GI disturbances, haematuria, headache, hearing disturbances, hypersensitivity reactions, insomnia, nausea, nervousness, photosensitivity, raised blood pressure, rashes, renal failure (especially in patients with preexisting renal impairment),tinnitus, vertigo. Rare: Hepatic damage, interstitial fibrosis associated with NSAIDs, Stevens-Johnson syndrome, toxic epidermal necrolysis, visual disturbances, exacerbation of symptoms in asthma, thrombo-cytopenia, aseptic meningitis

🤰 Pregnancy & Lactation Safety

Pregnancy Risk:
Caution advised, risk cannot be ruled out.
Lactation / Breastfeeding:
Caution advised

📚 Official Regulatory & Clinical References

  • Drug Regulatory Authority of Pakistan (DRAP): Drug Registration, S.R.O. Price Gazettes & National Essential Medicines List (NEML).
  • World Health Organization (WHO): Collaborating Centre for Drug Statistics Methodology (ATC/DDD Index).
  • Formulary Standards: British National Formulary (BNF) & Pakistan National Formulary (PNF) guidelines.
  • BRUFEN 200MG TAB — DRAP Registration Number: 000072
  • BRUFEN 400MG TAB — DRAP Registration Number: 001541
  • Brufen DS Suspension — DRAP Registration Number: 070851
  • Brufen Suspension — DRAP Registration Number: 004595
  • — DRAP Registration Number: 007850

Related Medicines

Medicines related to this brand, grouped by relevance.

Same generic: IBUPROFEN

ABURID
GLOBAL
Rs.220.00
ASTEGESIC
ASTELLAS
Rs.46.00
BLUDOL
STANDPHARM
Rs.81.50
Rs.233.75
Rs.50.31
BRUFLET
WINLET
Rs.56.00

More from ABBOTT

ABBOCIN
ABBOTT
Rs.96.20
ABBOWAX
ABBOTT
Rs.102.50
ABBUTOL
ABBOTT
Rs.172.53

Same category: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS

ABIDACAM
Z-JANS
Rs.96.00
ABXICAM
INNVOTEK
Rs.123.00
ACABEL
CONTINENTAL PHARMA
Rs.130.00

⚡ Quick Actions

💬 Share via WhatsApp